Simplex Trading, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.25 - $3.79 $3,025 - $9,171	2,420 New	2,420 $3,000
Q4 2023 Feb 02, 2024	BUY	$3.56 - $6.04 $14,282 - $24,232	4,012 Added 9.74%	45,212 $232,000
Q3 2023 Nov 01, 2023	BUY	$3.91 - $5.9 $42,024 - $63,413	10,748 Added 35.29%	41,200 $201,000
Q2 2023 Aug 04, 2023	BUY	$4.42 - $8.55 $134,597 - $260,364	30,452 New	30,452 $178,000
Q4 2022 Feb 02, 2023	SELL	$1.68 - $5.99 $19,807 - $70,622	-11,790 Reduced 53.37%	10,303 $43,000
Q3 2022 Nov 04, 2022	BUY	$0.14 - $2.66 $3,084 - $58,610	22,034 Added 37345.76%	22,093 $35,000
Q2 2022 Aug 03, 2022	SELL	$1.03 - $2.47 $1,325 - $3,178	-1,287 Reduced 95.62%	59 $0
Q1 2022 May 02, 2022	BUY	$1.61 - $3.01 $2,167 - $4,051	1,346 New	1,346 $3,000

9.96M

133K

43.9K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $23.1M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.